Ty21a-Ss

N/A

Report date: 2025/01/15 13:54:53

Base Information

Drug NameTy21a-Ss
Drug Alias NameShigella Ty21a-vectored vaccine (Shigella/Typhoid)Ty21a-Ss
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTyphoid FeverDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtein Potential LLC
China Registration ClassN/A

Develop Information

Active CompaniesProtein Potential LLCSanaria Inc
Inactive CompaniesN/A
Active IndicationsTyphoid FeverDysentery, Bacillary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A